These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5435619)

  • 21. The central action of gamma-butyrolactone and gamma-hydroxybutyrate.
    Ban T; Takaori S; Sasa M; Shimamoto K
    Jpn J Pharmacol; 1967 Mar; 17(1):30-45. PubMed ID: 5299973
    [No Abstract]   [Full Text] [Related]  

  • 22. [Central nervous activity and compared general pharmacology of glyoxylate, glycolate and glycolaldehyde].
    Laborit H; Baron C; London A; Olympie J
    Agressologie; 1971; 12(3):187-211. PubMed ID: 5122612
    [No Abstract]   [Full Text] [Related]  

  • 23. [Experimental analysis of interference between alpha-adrenergic stimulants with anti-hypertensive activity and the narcotic activity of pentobarbital].
    Caputi AP; Russo G; Scafuro MA; Turtur A; Lampa E; Sannino A; Nunziata A
    Arch Sci Med (Torino); 1978; 135(3):351-8. PubMed ID: 30418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on some aspects of the neuropharmacology of butylurea.
    Dar MS; Fakouhi T
    Arch Int Pharmacodyn Ther; 1974 Apr; 208(2):204-12. PubMed ID: 4854473
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on Withania ashwagandha Kaul. VI. The effect of the alkaloidal fractions (acetone, alcohol and water soluble) on the central nervous system.
    Prasad S; Malhotra CL
    Indian J Physiol Pharmacol; 1968 Oct; 12(4):175-81. PubMed ID: 5737360
    [No Abstract]   [Full Text] [Related]  

  • 26. 6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines which have central nervous system depressant activity.
    Hester JB; Rudzik AD; Kamdar BV
    J Med Chem; 1971 Nov; 14(11):1078-81. PubMed ID: 5165540
    [No Abstract]   [Full Text] [Related]  

  • 27. Augmented depression and reduced excitability of the central nervous system (CNS) by cadmium in the rat.
    Hall CE; Nasseth D; Hungerford S
    Pharmacol Biochem Behav; 1985 Apr; 22(4):619-21. PubMed ID: 3991770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prosopinine, an alkaloid from Prosopis africana (Legumineous). Its effects on the central and autonomic nervous systems].
    Bourrinet P; Quevauviller A
    C R Seances Soc Biol Fil; 1968; 162(5):1138-40. PubMed ID: 4236219
    [No Abstract]   [Full Text] [Related]  

  • 29. Potentiation of pentylenetetrazole and electroshock induced seizures by prostaglandin F2 alpha.
    Rosenkranz RP; Killam KF
    Proc West Pharmacol Soc; 1979; 22():43-5. PubMed ID: 515083
    [No Abstract]   [Full Text] [Related]  

  • 30. Involvement of a GABAergic mechanism in the anticonvulsant effect of pentobarbital against maximal electroshock-induced seizures in rats.
    Rastogi SK; Ticku MK
    Pharmacol Biochem Behav; 1985 Jan; 22(1):141-6. PubMed ID: 2983356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuro-pharmacological studies on SB 5833, a new psychotherapeutic agent of the benzodiazepine class.
    Ferrini R; Miragoli G; Taccardi B
    Arzneimittelforschung; 1974 Dec; 24(12):2029-32. PubMed ID: 4156177
    [No Abstract]   [Full Text] [Related]  

  • 32. THE ANTICONVULSANT ACTIVITY OF HYDROXYLAMINE.
    KOHLI RP; KISHOR K
    Arch Int Pharmacodyn Ther; 1965 Mar; 154():89-93. PubMed ID: 14346420
    [No Abstract]   [Full Text] [Related]  

  • 33. Convulsions elicited by handling: a sensitive method of measuring CNS excitation in mice treated with reserpine or convulsant drugs.
    Goldstein DB
    Psychopharmacologia; 1973 Aug; 32(1):27-32. PubMed ID: 4795489
    [No Abstract]   [Full Text] [Related]  

  • 34. Central nervous system depressants. 11. Benzodiazepines with ureas in the 2 position.
    Moffett RB; Rudzik AD
    J Med Chem; 1973 Nov; 16(11):1256-60. PubMed ID: 4747967
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of sodium fluoride on responses to various central nervous system agents in rats.
    LU FC; MAZURKIEWICZ IM; GREWAL RS; ALLMARK MG; BOIVIN P
    Toxicol Appl Pharmacol; 1961 Jan; 3():31-8. PubMed ID: 13763919
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pharmacological properties of the new neuroleptic of the phenothiazine series--dixyrazine].
    Mikhaĭlova TV; Terekhina AI; Gilev AP
    Farmakol Toksikol; 1969; 32(1):28-31. PubMed ID: 4388895
    [No Abstract]   [Full Text] [Related]  

  • 37. Chemistry and pharmacology of a series of substituted 4H-pyrazino[1,2-a]pyrimidin-4-ones.
    Trepanier DL; Rampy LW; Shriver KL
    J Med Chem; 1968 Sep; 11(5):1045-8. PubMed ID: 5697068
    [No Abstract]   [Full Text] [Related]  

  • 38. [Simple methods for the pharmacologic differentiation of central muscle relaxants].
    Hofrichter G; Roesch A; Roesch E; Schenk G
    Arzneimittelforschung; 1967 Feb; 17(2):242-5. PubMed ID: 5631491
    [No Abstract]   [Full Text] [Related]  

  • 39. The pharmacology of prazepam. A new benzodiazepine derivative.
    Robichaud RC; Gylys JA; Sledge KL; Hillyard IW
    Arch Int Pharmacodyn Ther; 1970 Jun; 185(2):213-27. PubMed ID: 4990742
    [No Abstract]   [Full Text] [Related]  

  • 40. Neuropharmacological actions of labetalol.
    Dadhich AP; Khanna NK; Vyas DS; Jain P
    Indian J Physiol Pharmacol; 1979; 23(1):39-43. PubMed ID: 437873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.